Thomson Medical Group's (SGX:A50) Malaysia-listed unit, TMC Life Sciences (KLSE:TMCLIFE), appointed Ahmad Adzuan Abdul Rahman as group chief executive officer.
Rahman takes over the role from Melvin Heng Jun Li, who has been redesignated from acting group CEO to non-executive director, according to a Monday filing with the Singapore Exchange.
Before joining TMC Life, Rahman was a founding member and advisor of Novotec Group. Prior to that, he was a regional managing director and executive vice president at IDS Medical Systems.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。